Volumen 10, Ausgabe 3 (2019)

Fallbericht

Patient with Primary T790M Mutation in Lung Adenocarcinoma Treated with Gefitinib as a First-Line and Osimertinib as a Second-Line Therapy: A Case Report

  • Daliborka Bursac, Tatjana Sarcev, Danica SazdanicVelikic, Nevena Djukic, Vanesa Sekurus, Svetlana Petkov and Goran Stojanovic

Forschungsartikel

Antitumor Activity of Atractylenolide II on Breast Cancer Cells through Regulation of Estrogen Receptor Protein Expression and NF-Kb Signaling Pathways

  • Chao Yang, MI Nasser, Shuoji Zhu, Chen Chen, Salah Adlat, Muqaddas Masood, Zhu Ping and Nan Jiang